ArticleBritish journal of cancer2013

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas.

Y Delpech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.